Overall Fundamental outlook

Business Operations:

Sector: Basic Materials
Industry: Specialty Chemicals

Clean Science and Technology Limited, research, develops, manufactures, and markets specialty chemicals in India and internationally. The company operates through Performance Chemicals, FMCG Chemicals, and Pharma & Agro Intermediates segments. It also offers FMCG Chemicals, including anisole, guaiacol, 4-methoxy acetophenone, butylated hydroxy anisole, veratrole, L-ascorbyl palmitate, tertiary butyl hydroquinone, ortho methoxy toluene, and para di-methoxy benzene (1,4-DMB). In addition, the company offers performance chemicals comprising clean light stab 770, 4-hydroxy tempo, mono methyl ether of hydroquinone, butylated hydroxy anisole, L-ascorbyl palmitate, 2,5-di-tertiary butyl hydroquinone, tertiary butyl hydroquinone, and dimethyl sebacate. Further, it provides pharma and agro intermediates, such as dicyclohexylcarbodimide, veratrole, para benzoquinone, and para di-methoxy benzene (1,4-DMB). Clean Science and Technology Limited serves food and infant food formulations, agricultural chemicals, polymers and monomers, perfumes, cosmetic, and other sectors. The company was incorporated in 2003 and is based in Pune, India.

Revenue projections:

Revenue projections for CLEAN
Revenue projections for CLEAN

Revenues for CLEAN are forecasted to decline from last year's levels, prompting caution among investors. When revenues fall, it can have a significant negative impact on the company's bottom line, reducing profitability and making the stock less attractive to risk-averse investors.

Financial Ratios:

currentRatio 0.00000
forwardPE 25.90834
debtToEquity 0.14200
earningsGrowth -0.30100
revenueGrowth -0.08800
grossMargins 0.61949
operatingMargins 0.24090
trailingEps 23.11000
forwardEps 2490.00460

CLEAN's Forward PE being in a reasonable range suggests the stock is fairly priced based on its earnings. The stock isn't overpriced, leaving room for growth, making it an attractive investment for those seeking opportunities for future value appreciation.
CLEAN's low growth in both earnings and revenue indicates a likely decrease in profits. This suggests the company may be facing financial challenges, and investors should be cautious about its future performance.
With positive gross and operating margins, CLEAN demonstrates strong profitability. This reflects the company's ability to manage costs and maintain healthy profits, showcasing effective operational efficiency and financial stability.
Clean Science and Technology Limited's forward EPS exceeding its trailing EPS means that the company is expected to increase profitability in the current financial year. This reflects improved earnings potential, signaling that Clean Science and Technology Limited is likely to outperform its previous year's financial performance.

Price projections:

Price projections for CLEAN
Price projections for CLEAN

Over time, analysts have gradually revised Clean Science and Technology Limited's price projections downward. This suggests growing concerns about the company's ability to meet previous expectations, pointing to a more conservative outlook.

Recommendation changes over time:

Recommendations trend for CLEAN
Recommendations trend for CLEAN


Analysts' buy bias for Clean Science and Technology Limited signals that the stock is considered a favorable investment. This outlook might prompt investors to allocate funds to Clean Science and Technology Limited, seeing it as a solid and profitable choice to park their money and potentially benefit from the company's long-term growth.